The Effect of In Vivo Interferon-Gamma on the Distribution of LFA-1 and ICAM-1 in Normal Human Skin

1989 ◽  
Vol 93 (4) ◽  
pp. 439-442 ◽  
Author(s):  
Jonathan N.W.N. Barker ◽  
Michael H Allen ◽  
Donald M MacDonald
1990 ◽  
Vol 122 (4) ◽  
pp. 451-458 ◽  
Author(s):  
J.N.W.N. BARKER ◽  
M.H. ALLEN ◽  
D.M. MACDONALD

2002 ◽  
Vol 76 (3) ◽  
pp. 301 ◽  
Author(s):  
Sergio Di Nuzzo ◽  
Regien M. R. Sylva-Steenland ◽  
Cornelis W. Koomen ◽  
Satoshi Nakagawa ◽  
Marielle van Breemen ◽  
...  

2003 ◽  
Vol 121 (4) ◽  
pp. 706-712 ◽  
Author(s):  
Lucinda D. Swindle ◽  
Steven G. Thomas ◽  
Michael Freeman ◽  
Peter M. Delaney

2004 ◽  
Vol 122 (5) ◽  
pp. 1277-1283 ◽  
Author(s):  
Mark Berneburg ◽  
Heidi Plettenberg ◽  
Kathrin Medve-König ◽  
Annette Pfahlberg ◽  
H. Gers-Barlag ◽  
...  

2020 ◽  
Vol 41 (Supplement_1) ◽  
pp. S78-S79
Author(s):  
Dorothy M Supp ◽  
Jennifer M Hahn ◽  
Christopher M Lloyd ◽  
Kelly A Combs ◽  
Viki B Swope ◽  
...  

Abstract Introduction Engineered skin substitutes (ESS) were developed to meet the need for prompt wound closure in patients with large full thickness burns. ESS containing autologous fibroblasts and keratinocytes were shown to provide stable wound closure in burn patients, but are limited by hypopigmentation. DNA damage caused by ultraviolet (UV) radiation is a known risk factor for development of skin cancer. In normal human skin, epidermal melanocytes provide pigmentation, helping to shield skin from UV-induced DNA damage. The current study investigated inclusion of human melanocytes (hM) and their role in the response of ESS to UV light in vivo. Methods Primary cells were isolated from skin of healthy de-identified human donors with IRB approval. Three groups of ESS were prepared with fibroblasts and keratinocytes, +/- hM, and were grafted orthotopically to immunodeficient mice: ESS without hM; ESS with light skin-derived (Caucasian) hM (ESS+hML); and ESS with dark skin-derived (African American) hM (ESS+hMD). After 8 weeks in vivo, grafts were irradiated with 135 mJ/cm2 UV, and mice were euthanized after 2 or 24 hours; non-UV treated mice served as controls. Pigmentation and erythema were measured with a Mexameter. Melanocytes and cyclobutane pyrimidine dimers (CPDs) were quantified by immunostaining with anti-TYRP1 and anti-CPD antibodies, respectively, followed by image analysis (Nikon Elements). Statistical analyses (SigmaPlot) utilized t-test or one-way ANOVA; P< 0.05 was considered significant. Results At 8 weeks post-grafting, mean hM density in ESS+hML and ESS+hMD was not significantly different from normal human skin samples. Pigmentation (in Mexameter units) before UV irradiation was significantly different among groups (ESS+hMD > ESS+hML > ESS no hM). UV irradiation did not increase erythema in any group, but resulted in significantly increased pigmentation in ESS+hML and ESS+hMD at 2 hours, but not 24 hours, post-UV. CPDs, the most prevalent form of UV-induced DNA damage, were significantly elevated 24 hours post-UV in ESS without hM. DNA damage was significantly lower 24 hours post-UV in ESS+hML and ESS+hMD compared with ESS without hM. No differences in DNA damage were observed between ESS+hML and ESS+hMD. Conclusions Pigmentation of ESS+hML and ESS+hMD in vivo varied according to the skin phototype of the hM donor, with no difference in melanocyte density, which was similar to normal human skin. Inclusion of either light or dark hM decreased UV-induced DNA damage, suggesting that hM in ESS play a photoprotective role, as in normal human skin. Applicability of Research to Practice Protection against UV-induced DNA damage may reduce the risk of skin cancer in patients grafted with ESS containing melanocytes.


2001 ◽  
Author(s):  
S. Fu ◽  
Teck-Chee Chia ◽  
Paul C. K. Lee ◽  
Sanjay M. Krishnan

1992 ◽  
Vol 98 (3) ◽  
pp. 384-387 ◽  
Author(s):  
Richard W Groves ◽  
Elizabeth Ross ◽  
Jonathan N W N Barker ◽  
Janet S Ross ◽  
Richard D R Camp ◽  
...  

1994 ◽  
Vol 303 (3) ◽  
pp. 863-867 ◽  
Author(s):  
D Chatellard-Gruaz ◽  
J H Saurat ◽  
G Siegenthaler

Cyclophilin A, the major intracellular binding protein for the immunosuppressive drug cyclosporin A (CsA), was studied in human keratinocytes during differentiation both in vivo and in vitro. Analysis of cyclophilin by gel-filtration radiobinding-assay with tritiated CsA showed one specific radioactive peak at 17 kDa. By this technique, the levels of cyclophilin (mean 55.23 +/- 8.43 pmol/mg protein) did not significantly differ during keratinocyte differentiation. When the protein extracts from calcium-induced differentiating keratinocytes and normal human skin were analysed by PAGE radiobinding-assay, two specific radioactive CsA-binding peaks were detected. The major peak (RF 0.13) was expressed in all samples (mean 47.32 +/- 17.53 pmol/mg protein) whereas the minor peak (RF 0.23) was dramatically decreased about 6-fold in abnormally differentiated skin (psoriasis) as well as in non-differentiated keratinocytes. At least six [3H]CsA-binding isoforms with pI values ranging from 5.58 to 7.75 were detected by isoelectrofocusing autoradio-blotting-assay in normal human skin; three of them immunoreacted with antibodies to cyclophilin. These results demonstrated the presence of several cyclophilin isoforms in human epidermal cells and an expression which correlated with the differentiation of human keratinocytes both in vivo and in vitro.


1991 ◽  
Vol 4 (2) ◽  
pp. 61-64 ◽  
Author(s):  
Leslie C. James ◽  
Alison M. Moore ◽  
Larry A. Wheeler ◽  
Gilliam M. Murphy ◽  
Pauline M. Dowd ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document